Publications by authors named "Mary Beth Carter"

Claim this Profile
P
Pyrazolone based TGFbetaR1 kinase inhibitors.
Kevin Guckian, Mary Beth Carter, Edward Yin-Shiang Lin, Michael Choi, Lihong Sun

Bioorg Med Chem Lett· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model.
Kai Fu, Michael J Corbley, Lihong Sun, Jessica E Friedman, Feng Shan, Mary Beth Carter

Arterioscler Thromb Vasc Biol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational design of potent and selective VLA-4 inhibitors and their utility in the treatment of asthma.
Juswinder Singh, Steve Adams, Mary Beth Carter, Hernan Cuervo, Wen-Cherng Lee

Curr Top Med Chem· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis